Literature DB >> 26612371

Superficial Fungal Infections.

Neha Kaushik1, George G A Pujalte2, Stephanie T Reese3.   

Abstract

Superficial fungal infections grow in dark and moist areas and invade various parts of the body. These infections are easily treatable in immunocompetent individuals. In immunosuppressed individuals, the presentation can be quite severe, requiring use of more potent antifungal agents. The treatment for these conditions consists of topical antifungal agents, creams, and oral systemic medications. The use of prednisone can alter the appearance of superficial fungal infections, making them difficult to diagnose. It is important for primary care providers to become adept at understanding the epidemiology, transmission, clinical presentation, diagnosis techniques, and treatment options available.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antifungal treatment; Candidiasis; Superficial fungal infection; Tinea barbae; Tinea capitis; Tinea corporis; Tinea pedis; Tinea versicolor

Mesh:

Substances:

Year:  2015        PMID: 26612371     DOI: 10.1016/j.pop.2015.08.004

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  12 in total

Review 1.  Tinea corporis: an updated review.

Authors:  Alexander Kc Leung; Joseph M Lam; Kin Fon Leong; Kam Lun Hon
Journal:  Drugs Context       Date:  2020-07-20

Review 2.  Epidemiology of fungal infections in China.

Authors:  Min Chen; Yuan Xu; Nan Hong; Yali Yang; Wenzhi Lei; Lin Du; Jingjun Zhao; Xia Lei; Lin Xiong; Langqi Cai; Hui Xu; Weihua Pan; Wanqing Liao
Journal:  Front Med       Date:  2018-01-11       Impact factor: 4.592

3.  Insight into the draft whole-genome sequence of the dermatophyte Arthroderma vanbreuseghemii.

Authors:  Mohamed Mahdi Alshahni; Tsuyoshi Yamada; Ayaka Yo; Somay Y Murayama; Makoto Kuroda; Yasutaka Hoshino; Jun Ishikawa; Shinichi Watanabe; Koichi Makimura
Journal:  Sci Rep       Date:  2018-10-11       Impact factor: 4.379

Review 4.  Antifungal Peptides as Therapeutic Agents.

Authors:  Miguel Fernández de Ullivarri; Sara Arbulu; Enriqueta Garcia-Gutierrez; Paul D Cotter
Journal:  Front Cell Infect Microbiol       Date:  2020-03-17       Impact factor: 5.293

Review 5.  Antifungal Polymeric Materials and Nanocomposites.

Authors:  Winnie Ntow-Boahene; David Cook; Liam Good
Journal:  Front Bioeng Biotechnol       Date:  2021-12-24

6.  Machine-learning based prediction of prognostic risk factors in patients with invasive candidiasis infection and bacterial bloodstream infection: a singled centered retrospective study.

Authors:  Yaling Li; Yutong Wu; Yali Gao; Xueli Niu; Jingyi Li; Mingsui Tang; Chang Fu; Ruiqun Qi; Bing Song; Hongduo Chen; Xinghua Gao; Ying Yang; Xiuhao Guan
Journal:  BMC Infect Dis       Date:  2022-02-13       Impact factor: 3.090

7.  Immunosuppressed Patients with Clinically Diagnosed Invasive Fungal Infections: The Fungal Species Distribution, Antifungal Sensitivity and Associated Risk Factors in a Tertiary Hospital of Anhui Province.

Authors:  Jinxing Xia; Zhongxin Wang; Tingting Li; Fanbo Lu; Daping Sheng; Wei Huang
Journal:  Infect Drug Resist       Date:  2022-02-02       Impact factor: 4.003

8.  Fungicidal Activity of AP10W, a Short Peptide Derived from AP-2 Complex Subunit mu-A, In Vitro and In Vivo.

Authors:  Yi Gong; Haoyi Li; Fei Wu; Yishuai Li; Shicui Zhang
Journal:  Biomolecules       Date:  2022-07-10

9.  Antimicrobial and cytotoxic activity of green synthesis silver nanoparticles targeting skin and soft tissue infectious agents.

Authors:  Javier Mussin; Viviana Robles-Botero; Rocío Casañas-Pimentel; Florencia Rojas; Letizia Angiolella; Eduardo San Martín-Martínez; Gustavo Giusiano
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

10.  Exposure to High Precariousness Prevalence Negatively Impacts Drug Prescriptions of General Practitioners to Precarious and Non-Precarious Populations: A Retrospective Pharmaco-Epidemiological Study.

Authors:  François Birault; Lakshmipriva Le Bonheur; Nicolas Langbour; Sandivanie Clodion; Nematollah Jaafari; Marie-Christine Perault-Pochat; Bérangère Thirioux
Journal:  Int J Environ Res Public Health       Date:  2022-03-03       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.